ADDING MULTIMEDIA ATryn(R) (Antithrombin [Recombinant]) Approved By The FDA (Medical News Today)
GTC Biotherapeutics ("GTC", NASDAQ: GTCB) and OVATION Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) approved ATryn (Antithrombin [Recombinant]) for the prevention of peri-operative and peri-partum thromboembolic events in hereditary antithrombin deficient patients.

FDA Advisory Committee Favors Approval Of DX-88 For Acute Attacks Of Hereditary Angioedema (Medical News Today)
Dyax Corp. (NASDAQ:DYAX) announced that the U.S. Food and Drug Administration's (FDA) Pulmonary-Allergy Advisory Committee voted (6 yes, 5 no, 2 abstentions) in favor of approval of DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE). If approved, DX-88 will be the first drug available in the U.S.

DRL launches 5 drugs in the US (Business Standard India)
Dr Reddy s Laboratories (DRL) on Sunday said the company has launched five generic drugs in the US market during the last month, which together have a potential market value of over $3.78 billion.